DOI:
10.1055/s-00000129
Kardiologie up2date
LinksClose Window
References
Gleim G. et al.
Abstract 683: Lipid-Altering Efficacy and Safety Profile of Co-administered Extended Release Niacin/Laropiprant and Simvastatin in Patients with Dyslipidemia.
Circulation 2007; 116: II_127-
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.